Icagen, Inc. (Nasdaq: ICGN) announced a one year extension to a prior worldwide collaboration and licensing agreement with Pfizer (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE